sorafenib has been researched along with guanosine triphosphate in 1 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (guanosine triphosphate) | Trials (guanosine triphosphate) | Recent Studies (post-2010) (guanosine triphosphate) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 14,728 | 25 | 2,115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Cui, L; Feng, S; Guo, X; Li, B; Ning, G; Wang, T; Wang, X; Wang, Z; Xia, Z; Yu, M; Yuan, W; Yuan, X; Zhang, L; Zhang, Y; Zhang, Z | 1 |
1 other study(ies) available for sorafenib and guanosine triphosphate
| Article | Year |
|---|---|
Sorafenib promotes sensory conduction function recovery via miR-142-3p/AC9/cAMP axis post dorsal column injury.
Topics: Adenylyl Cyclases; Animals; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Down-Regulation; Female; GAP-43 Protein; Guanosine Triphosphate; Interleukin-6; Isoquinolines; MicroRNAs; Phosphorylation; Rats; Recovery of Function; Rhodamines; RNA, Small Interfering; Sciatic Nerve; Sensation; Signal Transduction; Sorafenib; Spinal Cord Injuries; Sulfonamides; Tyrphostins; Up-Regulation | 2019 |